Among the risk factors for oral hypoglycemic drugs associated with hip fractures in patients with type 2 diabetes, the risk of "thiazolidinedione" is higher

Hip fractures are one of the most serious types of fracture injuries and are associated with chronic pain, disability, quality-adjusted loss of life, limited mobility, and significant loss of function, significantly increasing mortality and morbidity in

Many studies have estimated the cumulative incidence of hip fractures, but incidence data can only provide an estimate of an individual's age and sex-related risk over a short period of time, a factor that does not represent lifetime risk because mortality in hip fracture patients is an event rate

While many studies have explored factors associated with hip fracture events, studies of the lifelong risk of hip fractures in patients with type 2 diabetes are still limited and more data are needed to describe the effect of diabetes-related risk factors on the lifetime risk of

A retrospective cohort study was conducted on 25,275 men and 27,953 women with type 2 diabetes who participated in the diabetes case management program

There is a significant difference

Lifetime risk of hip fractures by risk factor subgroup

Considering all age groups, the lifetime risk of hip fractures is not significantly different between women aged < 65 years and men, but the lifetime risk of hip fractures in women after age 65 is much higher than in men

Hip fractures determined by the number of risk factors life expecta-males and b-males

In summary, cumulative lifetime risk provides an additional accurate estimate

References: Lin, C.